English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

European Commission

Russell Boniface | Sep 13, 2017

Merck's Keytruda wins European approval as bladder cancer treatment

Tabitha Fleming | Jun 2, 2017

European Commission approves dinutuximab beta for treating high-risk neuroblastoma

Robert Hadley | Apr 5, 2017

European Commission OKs Pfizer’s Xeljanz for rheumatoid arthritis treatment

Kyle Perrotti | Mar 17, 2017

European Reference Networks help patients with complex diseases find diagnosis, treatment

Amanda Rupp | Aug 9, 2016

Keytruda gains EC approval as advanced non-small cell lung cancer treatment

Amanda Rupp | Jun 8, 2016

Positive CHMP opinion granted for Amgen relapsed multiple myeloma treatment

Amanda Rupp | Jun 7, 2016

CHMP gives positive opinion of short bowl syndrome pediatric medicine

Amanda Rupp | Jun 2, 2016

Imbruvica gains approval for treating chronic lymphocytic leukemia

Trending

+ Pharmaceuticals
Patient Daily | Jun 2, 2025

PathAI collaborates with Northwestern Medicine on digital pathology advancements

+ Regulatory
Patient Daily | May 30, 2025

Alliance for Pharmacy Compounding calls for eliminating redundant, unauthorized, or ineffective regulation

+ Pharmaceuticals
Patient Daily | Jun 5, 2025

Exon 20 Group questions effectiveness of 340B drug program

+ Pharmaceuticals
Patient Daily | Jun 5, 2025

New study identifies indicators for HER2+ breast cancer therapy response



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily